Visit Drugdu.com(Ddu) at CPhI Worldwide Madrid 2018
September 30, 2018
Source: drugdu
537
Drugdu.com (Ddu), the leading global pharmaceuticals and medical devices B2B online platform, will attend CPhI Worldwide Madrid from 09. to 11. October 2018 in Spain. Welcome to visit our Booth12J2.
CPhI worldwide is the most important fair in the pharmaceutical industry and is held once a year at different locations around the world. In the meanwhile, Drugdu.com Online CPhI Expo 2018 make the connection between buyers and suppliers in a smart way, which means you can post sourcing request for your ideals pharmaceuticals products online effectively without a cost.
You can select the categories for sourcing requests on our drugdu.com, we have buyers and suppliers of Extracts, APIs, Formulations, Intermediates, Healthcare Products, and Pharmaceutical Machinery etc.
Click here to Post Sourcing Request for you ideal pharmaceuticals products on Drugdu.com now.
For more information about Drugdu.com (Ddu), visit our website at http://www.drugdu.com or follow us on Facebook, LinkedIn, Twitter, YouTube and Google Plus.
For business marketing and inquiries, please contact us at marketing@drugdu.com or call +86 400-106-9990.
By editor
Copyright©2024 Ddu. All rights reserved.
Read more on
- Cornerstone Pharmaceuticals has reached a strategic cooperation on anti-PD-L1 monoclonal antibodies in the Middle East and Africa regions November 22, 2024
- Hand in hand with Merck and acquire shares from Zhongsheng Pharmaceutical! Lixin Pharmaceutical has become a dark horse in the development of new drugs, with a total pipeline BD transaction volume exceeding 28 billion yuan November 22, 2024
- Junshi Biotechnology introduces two cancer dual target fusion protein drugs November 22, 2024
- China Biopharmaceuticals announces signing equity investment and strategic cooperation agreement with Lixin Pharmaceutical November 22, 2024
- As the industry is going down, more and more pharmaceutical companies are seeking to “exit”? November 22, 2024
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
